JP2009519895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009519895A5 JP2009519895A5 JP2008536730A JP2008536730A JP2009519895A5 JP 2009519895 A5 JP2009519895 A5 JP 2009519895A5 JP 2008536730 A JP2008536730 A JP 2008536730A JP 2008536730 A JP2008536730 A JP 2008536730A JP 2009519895 A5 JP2009519895 A5 JP 2009519895A5
- Authority
- JP
- Japan
- Prior art keywords
- xaa
- derived diffusible
- antibody
- diffusible ligand
- ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US2005/38125 | 2005-10-21 | ||
| US2005381125 | 2005-10-21 | ||
| PCT/US2006/040508 WO2007050359A2 (en) | 2005-10-21 | 2006-10-17 | Anti-addl monoclonal antibody and use thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2009519895A JP2009519895A (ja) | 2009-05-21 |
| JP2009519895A6 JP2009519895A6 (ja) | 2009-12-24 |
| JP2009519895A5 true JP2009519895A5 (https=) | 2012-04-05 |
| JP5289963B2 JP5289963B2 (ja) | 2013-09-11 |
Family
ID=39671607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008536730A Active JP5289963B2 (ja) | 2005-10-21 | 2006-10-17 | 抗ａｄｄｌモノクローナル抗体およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1940466B1 (https=) |
| JP (1) | JP5289963B2 (https=) |
| CN (1) | CN101291692A (https=) |
| AU (1) | AU2006306553B9 (https=) |
| CA (1) | CA2626783A1 (https=) |
| NO (1) | NO20082288L (https=) |
| RU (1) | RU2008120027A (https=) |
| WO (1) | WO2007050359A2 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1309341A2 (en) | 2000-07-07 | 2003-05-14 | Lars Lannfelt | Prevention and treatment of alzheimer's disease |
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| SE0401601D0 (sv) | 2004-06-21 | 2004-06-21 | Bioarctic Neuroscience Ab | Protofibril specific antibodies and uses thereof |
| PL2289909T3 (pl) | 2005-11-30 | 2015-04-30 | Abbvie Inc | Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał |
| RU2432362C2 (ru) | 2005-11-30 | 2011-10-27 | Эбботт Лэборетриз | Моноклональные антитела и их применения |
| RU2429244C2 (ru) | 2006-03-23 | 2011-09-20 | Байоарктик Ньюросайенс Аб | Улучшенные селективные в отношении протофибрилл антитела и их применение |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| EP2124952A2 (en) | 2007-02-27 | 2009-12-02 | Abbott GmbH & Co. KG | Method for the treatment of amyloidoses |
| US7931899B2 (en) | 2007-05-14 | 2011-04-26 | Medtronic, Inc | Humanized anti-amyloid beta antibodies |
| US8323654B2 (en) | 2007-05-14 | 2012-12-04 | Medtronic, Inc. | Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules |
| US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
| PL2170389T3 (pl) * | 2007-06-12 | 2015-03-31 | Ac Immune Sa | Humanizowane przeciwciało przeciw amyloidowi beta |
| US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
| RS53174B (sr) | 2007-10-05 | 2014-06-30 | Genentech Inc. | Upotreba antiamiloidnog beta antitela u slučaju oboljenja oka |
| EP2222700A2 (en) * | 2007-11-27 | 2010-09-01 | Medtronic, Inc. | Humanized anti-amyloid beta antibodies |
| WO2009079566A2 (en) | 2007-12-18 | 2009-06-25 | Acumen Pharmaceuticals, Inc. | Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production |
| EP2321338A1 (en) * | 2008-08-14 | 2011-05-18 | Merck Sharp & Dohme Corp. | Methods for purifying antibodies using protein a affinity chromatography |
| WO2011070174A1 (en) | 2009-12-11 | 2011-06-16 | Araclon Biotech, S.L. | Methods and reagents for improved detection of amyloid beta peptides |
| ES2684475T3 (es) | 2010-04-15 | 2018-10-03 | Abbvie Inc. | Proteínas que se unen a beta amiloide |
| CA2805414C (en) * | 2010-07-14 | 2020-07-07 | Merck Sharp & Dohme Corp. | Anti-addl monoclonal antibody and uses thereof |
| US9320793B2 (en) | 2010-07-14 | 2016-04-26 | Acumen Pharmaceuticals, Inc. | Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42 |
| US9176151B2 (en) | 2010-07-14 | 2015-11-03 | Acumen Pharmaceuticals, Inc. | Antibodies, kit and method for detecting amyloid beta oligomers |
| RU2607368C2 (ru) | 2010-07-30 | 2017-01-10 | Ац Иммуне С.А. | Безопасные и функциональные гуманизированные антитела |
| CN103298833B (zh) | 2010-08-14 | 2015-12-16 | Abbvie公司 | β淀粉样蛋白结合蛋白 |
| WO2012142301A2 (en) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury |
| EP2511296A1 (en) | 2011-04-12 | 2012-10-17 | Araclón Biotech, S. L. | Antibody, kit and method for determination of amyloid peptides |
| AU2012282825B2 (en) * | 2011-07-13 | 2016-05-26 | Merck Sharp & Dohme Corp. | Method for detection of amyloid beta oligomers in a fluid sample and uses thereof |
| JP6231263B2 (ja) * | 2012-07-17 | 2017-11-15 | 株式会社島津製作所 | アフィニティ支持体及びそれを用いた物質の捕捉方法 |
| EP3166970B1 (en) | 2014-07-10 | 2021-03-10 | BioArctic AB | Improved a-beta protofibril binding antibodies |
| WO2018156180A1 (en) | 2017-02-24 | 2018-08-30 | Kindred Biosciences, Inc. | Anti-il31 antibodies for veterinary use |
| WO2021055670A1 (en) | 2019-09-20 | 2021-03-25 | Avx Corporation | Somatic cell-based electrical biosensor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0683234B2 (en) * | 1993-01-25 | 2007-06-06 | Takeda Chemical Industries, Ltd. | Antibody against beta-amyloid or their derivative and use thereof |
| US5786180A (en) * | 1995-02-14 | 1998-07-28 | Bayer Corporation | Monoclonal antibody 369.2B specific for β A4 peptide |
| US20030068316A1 (en) | 1997-02-05 | 2003-04-10 | Klein William L. | Anti-ADDL antibodies and uses thereof |
| EP2006303A1 (en) * | 1997-04-09 | 2008-12-24 | Intellect Neurosciences, Inc. | Recombinant antibodies specific for Beta-Amyloid ends, DNA encoding and methods of use thereof |
| WO2004031400A2 (en) * | 2002-10-01 | 2004-04-15 | Northwestern University | Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules, and uses thereof |
| PE20050627A1 (es) * | 2003-05-30 | 2005-08-10 | Wyeth Corp | Anticuerpos humanizados que reconocen el peptido beta amiloideo |
| US7780963B2 (en) * | 2004-10-25 | 2010-08-24 | Merck & Co., Inc. | Anti-ADDL antibodies and uses thereof |
-
2006
- 2006-10-17 CA CA002626783A patent/CA2626783A1/en not_active Abandoned
- 2006-10-17 EP EP06836346A patent/EP1940466B1/en active Active
- 2006-10-17 RU RU2008120027/13A patent/RU2008120027A/ru not_active Application Discontinuation
- 2006-10-17 AU AU2006306553A patent/AU2006306553B9/en not_active Expired - Fee Related
- 2006-10-17 WO PCT/US2006/040508 patent/WO2007050359A2/en not_active Ceased
- 2006-10-17 JP JP2008536730A patent/JP5289963B2/ja active Active
- 2006-10-17 CN CNA2006800392637A patent/CN101291692A/zh active Pending
-
2008
- 2008-05-19 NO NO20082288A patent/NO20082288L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009519895A5 (https=) | ||
| KR102385495B1 (ko) | 항-cd71 활성화 가능한 항체 약물 접합체 및 이의 사용 방법 | |
| RU2007119382A (ru) | Антитела против addl и их применение | |
| RU2008120027A (ru) | Анти-addl моноклональное антитело и его применение | |
| JP2013542914A5 (https=) | ||
| JP2020526478A5 (https=) | ||
| CN104507964B (zh) | P2x7受体拮抗剂和激动剂 | |
| AU2016258988A1 (en) | Anti-ITGa3 antibodies, activatable anti-ITGa3 antibodies, and methods of use thereof | |
| CN105358175B (zh) | 用于治疗硬皮病的抗ccl2和抗loxl2组合疗法 | |
| JP2016020389A5 (https=) | ||
| JP2011528561A5 (https=) | ||
| JP2011523550A5 (https=) | ||
| WO2014052462A2 (en) | Activatable antibodies that bind interleukin-6 receptor and methods of use thereof | |
| RU2015126533A (ru) | Анти-cd47 антитела и способы их применения | |
| KR102599010B1 (ko) | 항-herv-k 엔벨로프 항체 및 그 용도 | |
| JP2013500941A5 (https=) | ||
| RU2013106270A (ru) | Моноклональное антитело против addl и его применения | |
| FI3553084T3 (fi) | Anti-adrenomedulliinivasta-aine (ADM) tai anti-ADM-vasta-ainefragmentti tai anti-ADM-non-Ig-skaffoldi elimen toimintahäiriön tai elimen vajaatoiminnan ehkäisemiseksi tai pienentämiseksi kroonisen tai akuutin taudin tai akuutin tilan omaavassa potilaassa | |
| JP2023509790A (ja) | α４β７インテグリン拮抗薬で炎症性腸疾患を治療するための方法 | |
| MD3191511T2 (ro) | Lianți TNF îmbunătățiți | |
| JP2021500376A (ja) | 特定のｄｐｐ３エピトープに指向され、そしてそれに結合するｄｐｐ３バインダー、ならびに酸化ストレスに関連する疾患／急性病態の予防または治療におけるその使用 | |
| US8883153B2 (en) | Methods for preventing and treating angioedema | |
| US20140242100A1 (en) | Methods and compositions for the generation and use of conformation-specific antibodies | |
| MX2014006265A (es) | Administacion del anticuerpo alfa4beta7 hetero-dimero-especifico. | |
| US10208108B2 (en) | Antibodies directed to ricin toxin |